Harmony Biosciences Holdings, Inc. HRMY Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s change in other liabilities?
- Harmony Biosciences Holdings, Inc. (HRMY) reported change in other liabilities of -$46.18M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s change in other liabilities changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s change in other liabilities decreased by 746.5% year-over-year, from -$5.46M to -$46.18M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s change in other liabilities?
- Over 3 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s change in other liabilities has grown at a 675.1% compound annual growth rate (CAGR), from -$146K to $67.99M.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.